Biosensors International (PINK:BSNRY) said it won a green light from European regulators for its BioMatrix NeoFlex drug-eluting stent, the latest in its DES line.
Stents
Tryton Medical launches side-branch stent in Europe
UPDATED May 17, 2013 with comment from Tryton CEO Shawn McCarthy.
Tryton Medical said it got the green light in Europe for its side-branch short coronary stent to treat bifurcation lesions in large vessels.
The new stent is 15mm, 3mm shorter in the main branch zone than the standard Tryton side-branch stent, the Durham, N.C.-based medical device company said.
St. Jude Medical wins EU green light for Ilumien Optis
St. Jude Medical (NYSE:STJ) today announced CE Mark approval of its Ilumien Optis PCI optimization system, designed to help physicians assess and treat patients with coronary artery disease.
Boston Scientific hits new 52-week high on WallFlex stent trial launch
Boston Scientific (NYSE:BSX) shares hit a new 52-week high today after the medical device company announced the launch of a clinical trial of its WallFlex biliary stent.
German court issues 2nd injunction against Boston Scientific in OrbusNeich stent patent spat
Elixir goes head-to-head against Medtronic with its DESyne Nx DES study
With a green-light from the FDA, Elixir Medical Corporation will move forward with its Excella III pivotal trial to review its DESyne Nx Novolimus-eluting coronary stent system. Elixir plans to enroll patients at 50 clinical locations and will use the trial results to support its upcoming premarket approval application.
OrbusNeich blocks German imports of Boston Scientific’s stents
OrbusNeich Medical wasted no time in enforcing a patent win against Boston Scientific (NYSE:BSX), announcing that it is blocking German imports of its rival’s cardiac stents.
Over-stenting trial settles ahead of cardiologist Midei’s testimony
The civil lawsuit filed by former patients against cardiologist Dr. Mark Midei and his former employer over alleged over-stenting settled on the eve of Midei’s testimony, reportedly without his agreement.
The lawsuit was filed against Midei and Catholic Health Initiatives, owner of the St. Joseph Medical Center where Midei practiced, by the more than 200 patients he’s accused of implanting with unnecessary stents.
Update: Cook Medical recalls Zilver PTX delivery system following patient death
Updated April 25, 2013 with additional comments from Cook Medical.
Cook Medical recalled all sizes, diameters and lot numbers of its Zilver PTX drug-eluting stents after receiving reports of 1 death and 1 patient injury possibly associated with a breakage in the catheter delivery system. It’s not clear when the devices will be back on the market, according to a company spokesman.